T-Rex 2X Inverse MSTR Daily Target ETF vs Workiva Inc — how do they compare? T-Rex 2X Inverse MSTR Daily Target ETF trades at $2.62 (market cap $94.46M), while Workiva Inc trades at $73.25 (market cap $4.01B). The key difference: Workiva Inc is far larger — about 42.5× T-Rex 2X Inverse MSTR Daily Target ETF's market cap, and Workiva Inc is trading nearer its 52-week high, T-Rex 2X Inverse MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold T-Rex 2X Inverse MSTR Daily Target ETF for 8 Days and Workiva Inc for 21 Days on average.
| MSTZ | WK | |
|---|---|---|
Market Cap | $94.46M | $4.01B |
Volume | 104,717,733 | 1,301,708 |
Sector | Leveraged / Inverse | Technology |
52-Week High | $27.92 | $93.31 |
52-Week Low | $2.29 | $44.31 |
Typical Hold Time | 8 Days | 21 Days |
Enterprise Value | — | $3.99B |
Signals from Pluang's Aura AI — not financial advice
MSTZ trades at $2.73, up 2.63% today, but technical indicators show a bearish trend with moving averages signaling caution. The stock lacks available fundamental data for key valuation and profitability metrics, making financial health assessment challenging. Recent ETF performance coverage highlights market volatility but provides no direct company-specific news.
The outlook is clouded by missing financials and bearish technicals. Investment opportunity hinges on future earnings visibility and competitive positioning. Key risks include potential weak fundamentals, market volatility, and lack of analyst coverage, requiring careful due diligence before consideration.
Workiva (WK) trades at $73.69, up 3.02% with strong technical momentum and bullish moving averages. The company shows impressive revenue growth with 2026 revenue reaching $966 million and net income turning positive at $47 million. Recent earnings beats and AI product innovations at Amplify 2026 conference highlight operational strength. Analyst sentiment remains overwhelmingly positive with 16 buy ratings and an $86 consensus price target.
WK presents a compelling growth story with improving profitability and strong analyst support, though elevated valuation multiples and technical overbought conditions warrant caution. The stock's 88.89% buy rating and 16.7% upside to consensus target suggest continued optimism, but investors should monitor execution of AI initiatives and competitive pressures in the regulatory technology space.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →Workiva is a leading provider of cloud-based platforms for complex reporting and compliance. It enables organizations to connect and manage data across financial reporting, ESG (Environmental, Social, and Governance), and GRC (Governance, Risk, and Compliance), serving as a single source of truth for auditable, transparent disclosures to regulators and stakeholders.
Read more on WK →